Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trialThe American heart journal, 2016-03, Vol.173, p.94-101 [Peer Reviewed Journal]Mosby, Inc. ;2015 Elsevier Inc. ;Copyright © 2015 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Mar 1, 2016 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2015.11.015 ;PMID: 26920601Full text available |
|
2 |
Material Type: Article
|
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and designThe American heart journal, 2020-11, Vol.229, p.61-69 [Peer Reviewed Journal]2020 The Author(s) ;Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved. ;2020. The Author(s) ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2020.07.008 ;PMID: 32916609Full text available |
|
3 |
Material Type: Article
|
Medication adherence: A call for actionThe American heart journal, 2011-09, Vol.162 (3), p.412-424 [Peer Reviewed Journal]Mosby, Inc. ;2011 Mosby, Inc. ;2015 INIST-CNRS ;Copyright © 2011 Mosby, Inc. All rights reserved. ;Copyright Elsevier Limited Sep 2011 ;ISSN: 0002-8703 ;ISSN: 1097-6744 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2011.06.007 ;PMID: 21884856 ;CODEN: AHJOA2Full text available |
|
4 |
Material Type: Article
|
Rheumatoid arthritis and cardiovascular diseaseThe American heart journal, 2013-10, Vol.166 (4), p.622-628.e1 [Peer Reviewed Journal]Mosby, Inc. ;2013 Mosby, Inc. ;2013 Mosby, Inc. All rights reserved. ;Copyright Elsevier Limited Oct 2013 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2013.07.010 ;PMID: 24093840 ;CODEN: AHJOA2Full text available |
|
5 |
Material Type: Article
|
ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetesThe American heart journal, 2018-04, Vol.198, p.135-144 [Peer Reviewed Journal]2017 The Authors ;Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved. ;2017. The Authors ;2017 The Authors 2017 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2017.12.006 ;PMID: 29653635Full text available |
|
6 |
Material Type: Article
|
Changes in comorbidities, diagnoses, therapies and outcomes in a contemporary cardiac intensive care unit populationThe American heart journal, 2019-09, Vol.215, p.12-19 [Peer Reviewed Journal]2019 Elsevier Inc. ;Copyright © 2019 Elsevier Inc. All rights reserved. ;2019. Elsevier Inc. ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2019.05.012 ;PMID: 31260901Full text available |
|
7 |
Material Type: Article
|
Effect of rosuvastatin 20 mg versus rosuvastatin 5 mg plus ezetimibe on statin side-effects in elderly patients with atherosclerotic cardiovascular disease: Rationale and design of a randomized, controlled SaveSAMS trialThe American heart journal, 2023-07, Vol.261, p.45-50 [Peer Reviewed Journal]2023 Elsevier Inc. ;Copyright © 2023 Elsevier Inc. All rights reserved. ;2023. Elsevier Inc. ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2023.03.002 ;PMID: 36934981Full text available |
|
8 |
Material Type: Article
|
Intensity of and adherence to lipid-lowering therapy as predictors of goal attainment and major adverse cardiovascular events in primary preventionThe American heart journal, 2024-03, Vol.269, p.118 [Peer Reviewed Journal]Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved. ;ISSN: 1097-6744 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2023.12.010 ;PMID: 38109988Digital Resources/Online E-Resources |
|
9 |
Material Type: Article
|
Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLEThe American heart journal, 2023-10, Vol.264, p.31-39 [Peer Reviewed Journal]2023 ;Copyright © 2023. Published by Elsevier Inc. ;Copyright Elsevier Limited Oct 2023 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2023.06.001 ;PMID: 37290700Full text available |
|
10 |
Material Type: Article
|
Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trialThe American heart journal, 2024-03, Vol.269, p.179 [Peer Reviewed Journal]Copyright © 2024 Elsevier Inc. All rights reserved. ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2023.12.004 ;PMID: 38160917Digital Resources/Online E-Resources |
|
11 |
Material Type: Article
|
Contemporary use of cardiovascular risk reduction strategies in type 2 diabetes. Insights from the diabetes collaborative registryThe American heart journal, 2023-09, Vol.263, p.104-111 [Peer Reviewed Journal]2023 Elsevier Inc. ;Copyright © 2023 Elsevier Inc. All rights reserved. ;2023. Elsevier Inc. ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2023.05.002 ;PMID: 37164146Full text available |
|
12 |
Material Type: Article
|
Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trialThe American heart journal, 2013-11, Vol.166 (5), p.823-830.e5 [Peer Reviewed Journal]Mosby, Inc. ;2013 Mosby, Inc. ;2013. ;Copyright Elsevier Limited Nov 2013 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2013.07.012 ;PMID: 24176437 ;CODEN: AHJOA2Full text available |
|
13 |
Material Type: Article
|
Smoking cessation and risk of recurrent cardiovascular events and mortality after a first manifestation of arterial diseaseThe American heart journal, 2019-07, Vol.213, p.112-122 [Peer Reviewed Journal]2019 The Authors ;Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. ;2019. The Authors ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2019.03.019 ;PMID: 31132583Full text available |
|
14 |
Material Type: Article
|
Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular diseaseThe American heart journal, 2022-07, Vol.249, p.12-22 [Peer Reviewed Journal]2022 Elsevier Inc. ;Copyright © 2022 Elsevier Inc. All rights reserved. ;2022. Elsevier Inc. ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2022.03.006 ;PMID: 35318028Full text available |
|
15 |
Material Type: Article
|
Socioeconomic disparities in healthcare utilization for atherosclerotic cardiovascular diseaseThe American heart journal, 2022-04, Vol.246, p.161-165 [Peer Reviewed Journal]2022 Elsevier Inc. ;Copyright © 2022 Elsevier Inc. All rights reserved. ;2022. Elsevier Inc. ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2022.01.011 ;PMID: 35093303Full text available |
|
16 |
Material Type: Article
|
The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristicsThe American heart journal, 2019-12, Vol.218, p.46-56 [Peer Reviewed Journal]2019 Elsevier Inc. ;Copyright © 2019 Elsevier Inc. All rights reserved. ;2019. Elsevier Inc. ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2019.09.011 ;PMID: 31706144Full text available |
|
17 |
Material Type: Article
|
Modeling the cost effectiveness and budgetary impact of Polypills for secondary prevention of cardiovascular disease in the United StatesThe American heart journal, 2019-08, Vol.214, p.77-87 [Peer Reviewed Journal]2019 Elsevier Inc. ;Copyright © 2019 Elsevier Inc. All rights reserved. ;2019. Elsevier Inc. ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2019.04.020 ;PMID: 31174054Full text available |
|
18 |
Material Type: Article
|
Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart StudyThe American heart journal, 2014-12, Vol.168 (6), p.878-883.e1 [Peer Reviewed Journal]Elsevier Inc. ;2014 Elsevier Inc. ;Copyright © 2014 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Dec 2014 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2014.08.007 ;PMID: 25458651 ;CODEN: AHJOA2Full text available |
|
19 |
Material Type: Article
|
Associations between β-blocker therapy and cardiovascular outcomes in patients with diabetes and established cardiovascular diseaseThe American heart journal, 2019-12, Vol.218, p.92-99 [Peer Reviewed Journal]2019 Elsevier Inc. ;Copyright © 2019 Elsevier Inc. All rights reserved. ;2019. Elsevier Inc. ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2019.09.013 ;PMID: 31715435Full text available |
|
20 |
Material Type: Article
|
Rationale and design of a nurse-led intervention to extend the HIV treatment cascade for cardiovascular disease prevention trial (EXTRA-CVD)The American heart journal, 2019-10, Vol.216, p.91-101 [Peer Reviewed Journal]2019 Elsevier Inc. ;Copyright © 2019 Elsevier Inc. All rights reserved. ;2019. Elsevier Inc. ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2019.07.005 ;PMID: 31419622Full text available |